You will receive alerts when there are new announcements on Allergy Therapeutics PLC
Only registered members can use this feature.
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments.
The broker now expects profits to around £5m higher than its previous forecasts at £2.9m.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.